Enhanced prediction of fracture risk combining vertebral fracture status and BMD

[1]  Harry K. Genant,et al.  Severity of vertebral fracture reflects deterioration of bone microarchitecture , 2006, Osteoporosis International.

[2]  H. Genant,et al.  Prognostic utility of a semiquantitative spinal deformity index. , 2005, Bone.

[3]  H. Genant,et al.  Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index. , 2005, Bone.

[4]  H. Genant,et al.  Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures , 2005, Osteoporosis International.

[5]  H. Genant,et al.  Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. , 2005, The Journal of clinical endocrinology and metabolism.

[6]  H. Genant,et al.  Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. , 2003, Bone.

[7]  H. Genant,et al.  Recognizing and reporting osteoporotic vertebral fractures , 2003, European Spine Journal.

[8]  M. Favus,et al.  Clinical utility of dual-energy vertebral assessment (DVA) , 2003, Osteoporosis International.

[9]  Ali Guermazi,et al.  Identification of vertebral fractures in osteoporosis. , 2002, Seminars in musculoskeletal radiology.

[10]  S. Cummings,et al.  Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.

[11]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[12]  P Geusens,et al.  Risk of new vertebral fracture in the year following a fracture. , 2001, JAMA.

[13]  K. Faulkner.  Chapter 59 – Clinical Use of Bone Densitometry , 2001 .

[14]  C. Wu,et al.  Vertebral fractures in osteoporosis: a new method for clinical assessment. , 2000, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[15]  T. Abbott,et al.  Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  R. Eastell,et al.  Identification of Vertebral Deformities in Women: Comparison of Radiological Assessment and Quantitative Morphometry Using Morphometric Radiography and Morphometric X‐Ray Absorptiometry , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  Kay Dickersin,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2000, NIH consensus statement.

[18]  G. M. Blake,et al.  Visual Assessment of Vertebral Deformity by X-ray Absorptiometry: A Highly Predictive Method to Exclude Vertebral Deformity , 2000, Osteoporosis International.

[19]  H K Genant,et al.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. , 1999, JAMA.

[20]  C C Glüer,et al.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. , 1999, JAMA.

[21]  J Pearson,et al.  Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  A. LaCroix,et al.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. , 1998, JAMA.

[23]  H K Genant,et al.  Comparative calibration without a gold standard. , 1997, Statistics in medicine.

[24]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[25]  S. Cummings,et al.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis , 1996 .

[26]  M. Nevitt,et al.  Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  C. Cooper,et al.  Incidence of clinically diagnosed vertebral fractures: A population‐based study in rochester, minnesota, 1985‐1989 , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  R. Epstein,et al.  Pre-existing fractures and bone mass predict vertebral fracture incidence in women. , 1991, Annals of internal medicine.

[29]  David W. Bates,et al.  CLINICAL USE OF BONE DENSITOMETRY , 1991 .

[30]  D. Bates,et al.  CLINICAL USE OF BONE DENSITOMETRY , 1991 .

[31]  S. Reiz,et al.  A New Method for Clinical Assessment of the Negative Inotropic Action of Anaesthetics ‐ With Special Reference to Isoflurane and its Effect on Myocardial Oxygenation , 1984, Acta anaesthesiologica Scandinavica.